Litcius/Paper detail

FXR: structures, biology, and drug development for NASH and fibrosis diseases

Siyu Tian, Shuming Chen, Chengxi Pan, Yong Li

2022Acta Pharmacologica Sinica76 citationsDOIOpen Access PDF

Topics & Concepts

Farnesoid X receptorObeticholic acidEnterohepatic circulationNonalcoholic fatty liver diseaseNuclear receptorFGF19Bile acidCholestasisMedicineDrug developmentPharmacologyInternal medicineFatty liverBioinformaticsBiologyDrugReceptorDiseaseTranscription factorBiochemistryAgonistFibroblast growth factorGeneDrug Transport and Resistance MechanismsLiver Diseases and ImmunityTrace Elements in Health
FXR: structures, biology, and drug development for NASH and fibrosis diseases | Litcius